Abstract
Objective The purpose of this study was to examine the concerns of brain health and wellness of former NCAA Division I (DI) football players compared to former NFL athletes.
Background This study aimed to understand how post-concussion symptoms, measured using the Neurobehavioral Symptom Inventory (NSI), compare between former NCAA DI football players and former NFL players, and how groups of former athletes describe the role that playing football had on their brain health.
Design/Methods We utilized a mixed methods design incorporating a survey of former NFL athletes and former NCAA DI football players (N = 150) and subsequent semi-structured interviews (N = 19). Survey data was analyzed using descriptive and inferential statistics; analysis of the interviews was descriptive.
Results Several themes were captured from the interviews, including (1) concerns about living with the consequences of concussions, (2) concerns for developing long-term sequelae from concussions and chronic traumatic encephalopathy (CTE), (3) rationalizing concerns for long-term effects or symptoms, (4) difficulties differentiating between normal aging and long-term effects of concussions, and (5) concerns for the long-term sequelae from concussions in current and former athletes at all levels of football. There was a significant difference in the number of concussions sustained between former NCAA DI football players and former NFL athletes, but no significant difference in the NSI scores or self-reported worry about future brain health, measured on a scale from 1-8.
Conclusions There was no significant difference in worry about brain health between former NFL and former NCAA DI football players despite former NCAA DI football players having significantly fewer self-reported concussions and less total playing time. This is significant for current and future healthcare professionals to recognize that worry about sequelae from concussions is individual to each patient. Players' concerns about brain health in relation to multiple concussions will be important to address in future research.
Footnotes
Disclosure: Mr. Fuller has nothing to disclose. Miss Jain has nothing to disclose. Mr. Nagirimadugu has nothing to disclose. Dr. Turner has received research support from National Institute on Aging of the National Institute of Health.
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard